☆ 4.6 Letter

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy

MOVEMENT DISORDERS (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Aurelija Jucaite et al.

Summary: In this study, PET imaging of TSPO showed significantly increased binding in MSA patients, with machine learning improving sensitivity. Glia imaging may support clinical MSA diagnosis and patient stratification in clinical trials on novel drug therapies.

MOVEMENT DISORDERS (2022)

Add to Collection

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Clinical Neurology

Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type

Sylvain Vergnet et al.

PARKINSONISM & RELATED DISORDERS (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

Katarina Varnas et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Add to Collection

Article Immunology

Microglial activation in Parkinson's disease using [18F]-FEPPA

Christine Ghadery et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment

Philipp T. Meyer et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.